Form 8-K/A - Current report: [Amend]
SEC Accession No. 0000200406-24-000036
Filing Date
2024-04-16
Accepted
2024-04-16 12:16:27
Documents
19
Period of Report
2024-04-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A jnj-20240416.htm   iXBRL 8-K/A 33774
2 EX-99.1 a2024q1exhibit9911.htm EX-99.1 63674
7 a1q24overallresultsv2.jpg GRAPHIC 20663
8 a1q24regionalsalesresultsv2.jpg GRAPHIC 10934
9 a1q24segmentsalesperforman.jpg GRAPHIC 11566
10 logo.jpg GRAPHIC 17029
  Complete submission text file 0000200406-24-000036.txt   373501

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT jnj-20240416.xsd EX-101.SCH 3333
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT jnj-20240416_def.xml EX-101.DEF 16713
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT jnj-20240416_lab.xml EX-101.LAB 30867
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT jnj-20240416_pre.xml EX-101.PRE 17560
22 EXTRACTED XBRL INSTANCE DOCUMENT jnj-20240416_htm.xml XML 6220
Mailing Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 732-524-2455
JOHNSON & JOHNSON (Filer) CIK: 0000200406 (see all company filings)

EIN.: 221024240 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-03215 | Film No.: 24846713
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)